U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech

The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.